AI
BLUE

Atria Investments’s bluebird bio BLUE Stock Holding History

Atria Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-151
Closed -$227K – 869
2019
Q2 		$227K Buy
151
+16
+12% +$27.7K 0.01% 856
2019
Q1 		$275K Buy
+135
New +$238K 0.01% 735
2018
Q4 		– Sell
-120
Closed -$216K – 887
2018
Q3 		$216K Buy
+120
New +$248K 0.01% 902
2017
Q4 		– Sell
-118
Closed -$210K – 824
2017
Q3 		$210K Buy
+118
New +$165K 0.01% 732

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Atria Investments's BLUE Position: Q3 2019 in Review

Atria Investments sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 151 shares — an estimated $227K sold.

Atria Investments first reported a position in BLUE in Q3 2017 and held it in 4 quarters. The position peaked at $275K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Atria Investments reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Atria Investments sold 151 bluebird bio shares in Q3 2019, an estimated $227K.
  • Atria Investments first reported a position in bluebird bio in Q3 2017 and held it in 4 quarters.
  • Atria Investments's bluebird bio position peaked at $275K in Q1 2019.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Atria Investments's 13F filing for Q3 2019, filed 14 Nov 2019.